About us

kodolifeScience
kodolifeScience
kodolifeScience
kodolifeScience

Kodo Lifescience Pvt Ltd is currently working as a contract development and manufacturing organization in order to address the critical raw material challenges for the Cell and Gene therapy market aiming to be the leading global supplier of pDNA

Kodo Lifescience is a contract development and manufacturing organization (CDMO) supporting its customers throughout the entire drug development lifecycle with the supply of biological pDNA raw material for early stage to late phase clinical stages and through to commercialisation with quality assurance and assurance of supply. We have our plug-and-play platform for pDNA manufacturing offering great efficiency and reliability, with a highly flexible approach to meet your process requirements.

Mission & Vision

Kodo Lifescience envisions to globally supply high quality GMP grade CGT raw materials to facilitate highly economical production of gene therapies and hence encourage a higher and a more effective adoption rate of these for life threatening, genetic, critical indications with unmet needs .

Revolution

Kodo Lifescience aims to address the global shortfall in supply and the requirement of high quality GMP grade raw materials for Cell and Gene therapy (CGT) drug products with the vision of increasing the adoption of these globally

kodolifeScience

Addressing high global cgt therapy demand & for ancilary products and gmp grade raw materials required for production

kodolifeScience

Solution

Cutting-edge Process Innovation and optimization in manufacturing process design, product development, biomanufacturing costs whilst ensuring sustainable economies of scale through a localised indigenous approach to ensure global supply of high quality GMP grade raw materials and associated services.


kodolifeScience

Features & Benefits

Features – Products

High quality Research, GMP-Like and GMP grade plasmid DNA with a highly optimized and streamlined process platform supplied at an optimised cost in order to ensure easier adoption and uptake of CGT therapies.

Benefits – Value Proposition

Kodo Lifescience strives to work in order drive down costs of CGT therapy with better COGs, ensure security of supply for critical raw materials and provide high quality plasmids for the customers process with a flexible approach in terms of scale-up, process development and manufacturing.

Our Teams

kodolifeScience
DIMPALKUMAR SHAH
An Established Entrepreneur with a rich background in Biopharmaceutic al Manufacturing and Real Estate Development